164 related articles for article (PubMed ID: 32858000)
41. Imaging Flow Cytometric Analysis of Stilbene-Dependent Apoptosis in Drug Resistant Human Leukemic Cell Lines.
Czop M; Bogucka-Kocka A; Kubrak T; Knap-Czop K; Makuch-Kocka A; Galkowski D; Wawer J; Kocki T; Kocki J
Molecules; 2019 May; 24(10):. PubMed ID: 31108853
[No Abstract] [Full Text] [Related]
42. Pharmacological inhibition of tumor anabolism and host catabolism as a cancer therapy.
Schcolnik-Cabrera A; Chavez-Blanco A; Dominguez-Gomez G; Juarez M; Vargas-Castillo A; Ponce-Toledo RI; Lai D; Hua S; Tovar AR; Torres N; Perez-Montiel D; Diaz-Chavez J; Duenas-Gonzalez A
Sci Rep; 2021 Mar; 11(1):5222. PubMed ID: 33664364
[TBL] [Abstract][Full Text] [Related]
43. Lack of Retinoblastoma Protein Shifts Tumor Metabolism from Glycolysis to OXPHOS and Allows the Use of Alternate Fuels.
Suresh Babu V; Dudeja G; Sa D; Bisht A; Shetty R; Heymans S; Guha N; Ghosh A
Cells; 2022 Oct; 11(20):. PubMed ID: 36291051
[TBL] [Abstract][Full Text] [Related]
44. Differential Utilization of Dietary Fatty Acids in Benign and Malignant Cells of the Prostate.
Dueregger A; Schöpf B; Eder T; Höfer J; Gnaiger E; Aufinger A; Kenner L; Perktold B; Ramoner R; Klocker H; Eder IE
PLoS One; 2015; 10(8):e0135704. PubMed ID: 26285134
[TBL] [Abstract][Full Text] [Related]
45. Combining lipoic acid to methylene blue reduces the Warburg effect in CHO cells: From TCA cycle activation to enhancing monoclonal antibody production.
Montégut L; Martínez-Basilio PC; da Veiga Moreira J; Schwartz L; Jolicoeur M
PLoS One; 2020; 15(4):e0231770. PubMed ID: 32298377
[TBL] [Abstract][Full Text] [Related]
46. Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells.
Li X; Han G; Li X; Kan Q; Fan Z; Li Y; Ji Y; Zhao J; Zhang M; Grigalavicius M; Berge V; Goscinski MA; Nesland JM; Suo Z
Oncotarget; 2017 Jul; 8(28):46363-46380. PubMed ID: 28624784
[TBL] [Abstract][Full Text] [Related]
47. Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase II alpha messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantrone.
Harker WG; Slade DL; Parr RL; Holguin MH
Cancer Res; 1995 Nov; 55(21):4962-71. PubMed ID: 7585537
[TBL] [Abstract][Full Text] [Related]
48. Glutathionylation of UCP2 sensitizes drug resistant leukemia cells to chemotherapeutics.
Pfefferle A; Mailloux RJ; Adjeitey CN; Harper ME
Biochim Biophys Acta; 2013 Jan; 1833(1):80-9. PubMed ID: 23069211
[TBL] [Abstract][Full Text] [Related]
49. Effects of enhancing mitochondrial oxidative phosphorylation with reducing equivalents and ubiquinone on 1-methyl-4-phenylpyridinium toxicity and complex I-IV damage in neuroblastoma cells.
Mazzio EA; Soliman KF
Biochem Pharmacol; 2004 Mar; 67(6):1167-84. PubMed ID: 15006552
[TBL] [Abstract][Full Text] [Related]
50. Enhanced cellular respiration in cells exposed to doxorubicin.
Souid AK; Penefsky HS; Sadowitz PD; Toms B
Mol Pharm; 2006; 3(3):307-21. PubMed ID: 16749863
[TBL] [Abstract][Full Text] [Related]
51. Assessment of the low inhibitory specificity of oxamate, aminooxyacetate and dichloroacetate on cancer energy metabolism.
Moreno-Sánchez R; Marín-Hernández Á; Del Mazo-Monsalvo I; Saavedra E; Rodríguez-Enríquez S
Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3221-3236. PubMed ID: 27538376
[TBL] [Abstract][Full Text] [Related]
52. In vitro treatment of HepG2 cells with saturated fatty acids reproduces mitochondrial dysfunction found in nonalcoholic steatohepatitis.
García-Ruiz I; Solís-Muñoz P; Fernández-Moreira D; Muñoz-Yagüe T; Solís-Herruzo JA
Dis Model Mech; 2015 Feb; 8(2):183-91. PubMed ID: 25540128
[TBL] [Abstract][Full Text] [Related]
53. CFTR Deletion Confers Mitochondrial Dysfunction and Disrupts Lipid Homeostasis in Intestinal Epithelial Cells.
Kleme ML; Sané A; Garofalo C; Seidman E; Brochiero E; Berthiaume Y; Levy E
Nutrients; 2018 Jun; 10(7):. PubMed ID: 29954133
[TBL] [Abstract][Full Text] [Related]
54. HBx regulates fatty acid oxidation to promote hepatocellular carcinoma survival during metabolic stress.
Wang MD; Wu H; Huang S; Zhang HL; Qin CJ; Zhao LH; Fu GB; Zhou X; Wang XM; Tang L; Wen W; Yang W; Tang SH; Cao D; Guo LN; Zeng M; Wu MC; Yan HX; Wang HY
Oncotarget; 2016 Feb; 7(6):6711-26. PubMed ID: 26744319
[TBL] [Abstract][Full Text] [Related]
55. Targeting Tumor Mitochondrial Metabolism Overcomes Resistance to Antiangiogenics.
Navarro P; Bueno MJ; Zagorac I; Mondejar T; Sanchez J; Mourón S; Muñoz J; Gómez-López G; Jimenez-Renard V; Mulero F; Chandel NS; Quintela-Fandino M
Cell Rep; 2016 Jun; 15(12):2705-18. PubMed ID: 27292634
[TBL] [Abstract][Full Text] [Related]
56. AMP-Activated Protein Kinase Regulates Oxidative Metabolism in Caenorhabditis elegans through the NHR-49 and MDT-15 Transcriptional Regulators.
Moreno-Arriola E; El Hafidi M; Ortega-Cuéllar D; Carvajal K
PLoS One; 2016; 11(1):e0148089. PubMed ID: 26824904
[TBL] [Abstract][Full Text] [Related]
57. Characterization of a novel metabolic strategy used by drug-resistant tumor cells.
Harper ME; Antoniou A; Villalobos-Menuey E; Russo A; Trauger R; Vendemelio M; George A; Bartholomew R; Carlo D; Shaikh A; Kupperman J; Newell EW; Bespalov IA; Wallace SS; Liu Y; Rogers JR; Gibbs GL; Leahy JL; Camley RE; Melamede R; Newell MK
FASEB J; 2002 Oct; 16(12):1550-7. PubMed ID: 12374777
[TBL] [Abstract][Full Text] [Related]
58. Targeting Mitochondria in Melanoma.
Aminzadeh-Gohari S; Weber DD; Catalano L; Feichtinger RG; Kofler B; Lang R
Biomolecules; 2020 Sep; 10(10):. PubMed ID: 33007949
[TBL] [Abstract][Full Text] [Related]
59. Resistance to energy metabolism - targeted therapy of AML cells residual in the bone marrow microenvironment.
Tabe Y; Konopleva M
Cancer Drug Resist; 2023; 6(1):138-150. PubMed ID: 37065866
[TBL] [Abstract][Full Text] [Related]
60. Comparative energy metabolism in cultured heart muscle and HeLa cells.
Stanisz J; Wice BM; Kennell DE
J Cell Physiol; 1983 Jun; 115(3):320-30. PubMed ID: 6853608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
